HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MEK inhibition leads to lysosome-mediated Na+/I- symporter protein degradation in human breast cancer cells.

Abstract
The Na(+)/I(-) symporter (NIS (SLC5A5)) is a transmembrane glycoprotein that mediates active iodide uptake into thyroid follicular cells. NIS-mediated iodide uptake in thyroid cells is the basis for targeted radionuclide imaging and treatment of differentiated thyroid carcinomas and their metastases. Furthermore, NIS is expressed in many human breast tumors but not in normal non-lactating breast tissue, suggesting that NIS-mediated radionuclide uptake may also allow the imaging and targeted therapy of breast cancer. However, functional cell surface NIS expression is often low in breast cancer, making it important to uncover signaling pathways that modulate NIS expression at multiple levels, from gene transcription to posttranslational processing and cell surface trafficking. In this study, we investigated NIS regulation in breast cancer by MAPK/extracellular signal-regulated kinase (ERK) kinase (MEK) signaling, an important cell signaling pathway involved in oncogenic transformation. We found that MEK inhibition decreased NIS protein levels in all-trans retinoic acid/hydrocortisone-treated MCF-7 cells as well as human breast cancer cells expressing exogenous NIS. The decrease in NIS protein levels by MEK inhibition was not accompanied by a decrease in NIS mRNA or a decrease in NIS mRNA export from the nucleus to the cytoplasm. NIS protein degradation upon MEK inhibition was prevented by lysosome inhibitors but not by proteasome inhibitors. Interestingly, NIS protein level was correlated with MEK/ERK activation in human breast tumors from a tissue microarray. Taken together, MEK activation appears to play an important role in maintaining NIS protein stability in human breast cancers.
AuthorsZhaoxia Zhang, Sasha Beyer, Sissy M Jhiang
JournalEndocrine-related cancer (Endocr Relat Cancer) Vol. 20 Issue 2 Pg. 241-50 (Apr 2013) ISSN: 1479-6821 [Electronic] England
PMID23404856 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Butadienes
  • Iodides
  • Nitriles
  • Protein Kinase Inhibitors
  • RNA, Messenger
  • Symporters
  • U 0126
  • sodium-iodide symporter
  • Tretinoin
  • Mitogen-Activated Protein Kinase Kinases
  • Hydrocortisone
Topics
  • Breast Neoplasms (metabolism)
  • Butadienes (pharmacology)
  • Cell Line, Tumor
  • Humans
  • Hydrocortisone (pharmacology)
  • Iodides (metabolism)
  • Lysosomes (metabolism)
  • Mitogen-Activated Protein Kinase Kinases (antagonists & inhibitors)
  • Nitriles (pharmacology)
  • Protein Kinase Inhibitors (pharmacology)
  • Proteolysis
  • RNA, Messenger (metabolism)
  • Symporters (genetics, metabolism)
  • Tretinoin (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: